April 8, 2026
1 min read

Shionogi nabs initial $119M award from BARDA to establish US antibiotic plant

Japan’s Shionogi is joining the spate of drugmakers to unveil a U.S. manufacturing commitment, albeit under slightly different circumstances than its peers.

Leave a Reply

Your email address will not be published.

Previous Story

More Drugmakers Join TrumpRx MedNews

Next Story

STAT+: 23andMe finds genetic changes appear to help predict response to GLP-1 drugs for weight loss

Previous Story

More Drugmakers Join TrumpRx MedNews

Next Story

STAT+: 23andMe finds genetic changes appear to help predict response to GLP-1 drugs for weight loss

Latest from Blog

Go toTop